We first assessed whether the BV2 cells were effectively activated by quantifying the mRNA levels of IL-1β, a representative indicator of BV2 cell activation, and measured the levels of IL-1β in cell culture supernatants of the group before and after transfection and before and after infection. The gene discussed is IL1B; the disease is infection.